Medtronic's BrainSense™ Adaptive Deep Brain Stimulation System Receives FDA Approval

Feb 28, 2025 07:02 CST Updated 07:02

Medtronic

Medical Device Manufacturer

2025Year2Month24Day,Medtronic's World's First Closed-Loop FunctionBrainSense™ Adaptive Deep Brain Stimulation (aDBS，Adaptive deep brain stimulation) andBrainSense™ Electrode Identifier (EI，Electrode Identifier) Obtain U.S.FDAApproval. Subsequently1Month Obtained EUCEAfter approval, this groundbreaking technology has once again been successfully obtained.FDAApproval Marks Milestone Breakthrough in Application of Closed-Loop Stimulation Technology, Usual Individualized Precision Treatment Enters New Era.

Deep Brain Stimulation (DBS), commonly known as "brain pacemaker," involves electrodes implanted in the brain that emit electrical pulses to stimulate specific nuclei deep in the brain, thereby improving patients' symptoms and quality of life. It has been approved for treating Parkinson’s disease, essential tremor, dystonia, and drug-resistant epilepsy.

1987In the year, Medtronic collaborated with French neurosurgeons.BenabidProfessor Successfully Performs World's First Deep Brain Stimulation Surgery,1999The therapy officially entered China in the year, and so far, its global clinical application has exceeded35Year.

To help every patient better address the challenges brought by disease progression and achieve personalized precision treatment, Medtronic has developedAdaptive Brain Stimulator with Closed-loop Function (aDBS）Capable of sensing brain signals while providing electrical stimulation therapy to patients, and dynamically adjusting the treatment in real time based on changes in the patient's brain state, reducing the need and inconvenience of manual stimulation adjustments. This creates more treatment possibilities for patients and provides clinicians with a powerful tool for researching and even overcoming diseases.

As a witness, participant, and contributor to the rapid development of China's healthcare industry, Medtronic has always..."In China, for China", Adhering to"Alleviate pain, restore health, and extend life"'s mission, to continuously and accelerate the introduction of innovative cutting-edge technologies,ExpectationsaDBSThe sooner it arrives, the more extraordinary changes it will bring to the lives of patients in China.。

*Statement —— The products involved in this article have not yet been launched in China. The content of this article is for news and scientific purposes only and should not be considered as a recommendation or proof of efficacy for the medical products involved. For matters related to disease diagnosis, treatment, and rehabilitation, please be sure to visit professional medical institutions for consultation and seek professional advice. If any individual or other media outlet or website wishes to reproduce this article, please contact this official account for authorization and indicate the source of the reprint.